State Street Corp Bluebird Bio, Inc. Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, State Street Corp holds 3,841,923 shares of BLUE stock, worth $29.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,841,923

Previous 3,798,541 1.14%

Holding current value

$29.4 Million

Previous $3.72 Million 46.35%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$0.47 - $1.35 $20,389 - $58,565	43,382 Added 1.14%	3,841,923 $2 Million
Q2 2024 Aug 14, 2024	BUY	$0.85 - $1.26 $314,845 - $466,711	370,406 Added 10.8%	3,798,541 $3.72 Million
Q1 2024 May 15, 2024	SELL	$0.91 - $1.75 $9.5 Million - $18.3 Million	-10,437,584 Reduced 75.28%	3,428,135 $4.39 Million
Q4 2023 Feb 14, 2024	BUY	$1.32 - $4.83 $1.58 Million - $5.8 Million	1,200,603 Added 9.48%	13,865,719 $19.1 Million
Q3 2023 Nov 14, 2023	SELL	$3.02 - $4.05 $11.2 Million - $15 Million	-3,693,014 Reduced 22.58%	12,665,116 $38.5 Million
Q2 2023 Aug 14, 2023	SELL	$2.79 - $5.03 $3.93 Million - $7.08 Million	-1,407,416 Reduced 7.92%	16,358,130 $53.8 Million
Q1 2023 May 15, 2023	BUY	$3.14 - $8.22 $15.7 Million - $41.1 Million	5,006,075 Added 39.23%	17,765,546 $56.5 Million
Q4 2022 Feb 14, 2023	BUY	$5.77 - $8.49 $224,978 - $331,033	38,991 Added 0.31%	12,759,471 $88.3 Million
Q3 2022 Nov 15, 2022	BUY	$3.75 - $7.39 $40.9 Million - $80.5 Million	10,895,379 Added 596.97%	12,720,480 $80.5 Million
Q2 2022 Aug 15, 2022	SELL	$2.94 - $5.23 $33.3 Million - $59.2 Million	-11,326,790 Reduced 86.12%	1,825,101 $7.56 Million
Q1 2022 May 16, 2022	BUY	$4.07 - $10.6 $22.5 Million - $58.7 Million	5,534,581 Added 72.66%	13,151,891 $63.8 Million
Q4 2021 Feb 14, 2022	BUY	$8.96 - $16.31 $28.2 Million - $51.3 Million	3,147,374 Added 70.41%	7,617,310 $76.1 Million
Q3 2021 Nov 15, 2021	BUY	$11.24 - $21.0 $19.4 Million - $36.3 Million	1,729,274 Added 63.1%	4,469,936 $85.4 Million
Q2 2021 Aug 16, 2021	BUY	$18.04 - $22.09 $5.75 Million - $7.04 Million	318,909 Added 13.17%	2,740,662 $87.6 Million
Q1 2021 May 17, 2021	BUY	$16.59 - $33.89 $2.17 Million - $4.44 Million	130,891 Added 5.71%	2,421,753 $73 Million
Q4 2020 Feb 16, 2021	BUY	$27.5 - $37.92 $15.6 Million - $21.6 Million	568,440 Added 33.0%	2,290,862 $99.1 Million
Q3 2020 Nov 10, 2020	BUY	$34.44 - $43.75 $2.75 Million - $3.5 Million	79,940 Added 4.87%	1,722,422 $92.9 Million
Q2 2020 Aug 14, 2020	BUY	$27.12 - $45.97 $2.73 Million - $4.62 Million	100,513 Added 6.52%	1,642,482 $100 Million
Q1 2020 May 11, 2020	BUY	$26.16 - $63.5 $40.3 Million - $97.9 Million	1,541,969 New	1,541,969 $70.9 Million

Others Institutions Holding BLUE

# of Institutions

150

Shares Held

63.4M

Call Options Held

264K

Put Options Held

428K

View Full List

About bluebird bio, Inc.

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $591M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

More about BLUE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Bluebird Bio, Inc. Transaction History